Ami Klin, PhD

Ami Klin, PhD, is the Georgia Research Alliance Eminent Scholar Professor, the Bernie Marcus Distinguished Chair in Autism, Chief of the Division of Autism and Neurodevelopment at Emory University School of Medicine, and Director of the Marcus Autism Center, Children’s Healthcare of Atlanta. He obtained his PhD from the University of London, and completed clinical and research post-doctoral fellowships at the Yale Child Study Center. He directed the Autism Program at the Yale Child Study Center, Yale University School of Medicine until 2010, where he was the Harris Professor of Child Psychology & Psychiatry. Dr. Klin’s primary research activities focus on social mind and social brain, and on developmental aspects of autism from infancy through adulthood. These studies include eye-tracking based methodologies co-directed with Warren Jones, which allow researchers to see the world through the eyes of individuals with autism. These techniques led to the clinical validation of EarliPoint, a biomarker-based objective and quantitative tool for the diagnosis and assessment of young children with autism cleared by the FDA for broad clinical implementation for children aged 16 months to 8 years. Dr. Klin is the author of over 250 scientific publications in the field of autism and related conditions.